✦ LIBER ✦

Disease status at transplant impacts lymphocyte and platelet recovery after allogeneic peripheral blood stem cell transplant (PBSCT) for patients with AML/MDS

✍ Scribed by R.M. Saliba; B. Oran; S. Giralt; K. Komanduri; A. Carrasco-Yalan; S. Ghosh; R. Champlin; M. de Lima

Book ID: 116278575
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 70 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.11.131

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Cytogenetics and Marrow Remiss

Impact of Cytogenetics and Marrow Remission Status on Disease Progression in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Stem Cell Transplantation

✍ E. Koca; R.M. Saliba; M. de Lima; U. Popat; P. Kebriaei; G. Rondon; W. Zhang; S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Liver function tests and absolute lympho

Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant

✍ Fernando Silva; José A. Pérez-Simón; Teresa Caballero Velazquez; Cristina Encina 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

The 2009 American Society of Hematology (ASH) annual meeting introduced novel strategies for the treatment of acute leukemia. Targeted inhibitors for both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) represent the future of these malignancies. Inclusion of targeted treatment t

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

✍ A. Shimoni; N. Shem-Tov; A. Rand; Y. Volchek; R. Yerushalmi; I. Hardan; A. Nagle 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB